HSBC Holdings’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

HSBC Holdings’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-31,631	Closed	-$84K	–	2961
2020 Q1	$84K	Sell	31,631 -9,552	-23%	-$15.7K	﹤0.01%	2496
2019 Q4	$47K	Sell	41,183 -41,061	-50%	-$65.6K	﹤0.01%	2972
2019 Q3	$141K	Buy	+82,244	New	+$250K	﹤0.01%	2941

HSBC Holdings's NTGN Position: Q2 2020 in Review

HSBC Holdings sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 31,631 shares — an estimated $84K sold.

HSBC Holdings first reported a position in NTGN in Q3 2019 and held it in 3 quarters. The position peaked at $141K in Q3 2019. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

HSBC Holdings reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
HSBC Holdings sold 31,631 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $84K.
HSBC Holdings first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
HSBC Holdings's Neon Therapeutics, Inc. Common Stock position peaked at $141K in Q3 2019.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on HSBC Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.